相关实验视频
Updated: Sep 9, 2025

06:47
A Murine Model of Vertical Sleeve Gastrectomy
Published on: December 18, 2017
11.2K
袖子胃切除术后的GLP-1和GIP变化以及青少年的重量增加. 我们需要一个提升吗?
Mohamed Shehata1, Ahmed Elhaddad2, Mohamed Mansour2
1Tanta University, Tanta, Egypt. mohamedshehata81@hotmail.com.
Obesity surgery
|August 31, 2025
概括
袖子胃切除术有效降低了青少年的体重,但体重可以恢复. 在一些患者中,塞马格卢提德治疗有助于逆转体重增加,显示GLP- 1激动剂的潜力.
科学领域:
- 腹部外科和代谢研究
- 青少年内分泌和体重管理
背景情况:
- 袖子胃切除术 (LSG) 是青少年常见的减肥手术.
- 长期的成功受到重量增加和可变的荷尔蒙变化的影响.
- 了解LSG后的内激素 (GLP-1,GIP) 动态至关重要.
研究的目的:
- 在青少年进行LSG后评估长期体重轨迹和内激素水平.
- 评估赛马格卢提德作为LSG后体重恢复的辅助疗法的有效性.
主要方法:
- 对264名接受LSG的青少年进行回顾性分析,追踪时间为5年.
- 年度测量体重,BMI,总体重减轻率 (TWL%),多余体重减轻率 (EWL%),GLP-1和GIP.
- 在18个月后,体重恢复 (WR) 定义为≥10%的体重增加加上<50%的EWL;62名患者从第3年开始接受西马格卢提德.
主要成果:
- 平均体重在LSG后显著下降,EWL百分比达到68%,到第5年下降至63%.
- 素水平 (GLP-1,GIP) 最初增加,然后降低;在WR患者中观察到较低的水平.
- 在一年内,在WR患者中,塞马格卢提德治疗的平均EWL从34%增加到68%;代谢并发症有所改善.
结论:
- 在青少年中,LSG提供持续的减肥和代谢效益.
- 随着时间的推移,对LSG的激素反应减弱,特别是在重量增加的人群中.
- 作为青少年在LSG后恢复体重的辅助疗法,塞马格卢提德具有前景.
相关概念视频
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Insulin: Dosing Regimen and Adverse Effects
253
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
253
Dipeptidyl Peptidase 4 Inhibitors
252
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
252
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Oral Hypoglycemic Agents: Glinides
256
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
256
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K

